Published in Am J Physiol on April 01, 1987
Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut (1991) 1.32
Neuroendocrine disorders of the gut. West J Med (1995) 1.01
Acid peptic diseases: pharmacological approach to treatment. Expert Rev Clin Pharmacol (2009) 1.00
Differential control of somatostatin messenger RNA in rat gastric corpus and antrum. Role of acid, food, and capsaicin-sensitive afferent neurons. J Clin Invest (1993) 0.93
Vagal regulation of acid secretion and gastrin release. Yale J Biol Med (1996) 0.92
Genetic dissection of the signaling pathways that control gastric acid secretion. Inflammopharmacology (2005) 0.81
Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci (1995) 0.80
The mechanism of inhibitory action of secretin on gastric acid secretion in conscious rats. J Physiol (1995) 0.76
Lack of cholinergic innervation in gastric mucosa does not affect gastrin secretion or basal acid output in neurturin receptor GFRα2 deficient mice. J Physiol (2013) 0.75
Effects of enprostil on gastric endocrine secretion during chronic administration of lansoprazole. J Gastroenterol (1997) 0.75
Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun (1989) 3.03
Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun (1971) 2.67
Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science (1971) 2.43
Histamine, acting via H3 receptors, inhibits somatostatin and stimulates acid secretion in isolated mouse stomach. Gastroenterology (1997) 2.31
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun (1971) 2.29
Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science (1975) 2.00
A quantitative statement of the two-component hypothesis of gastric secretion. Gastroenterology (1966) 1.92
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. Am J Physiol (1992) 1.84
The neuroendocrine design of the gut. The play of chemicals in a chemical playground. Gastroenterology (1974) 1.73
G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol (1998) 1.67
Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus. Proc Natl Acad Sci U S A (1980) 1.54
Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun (1990) 1.52
The regional distribution of somatostatin in the rat brain. Endocrinology (1975) 1.48
Isolation and structure of somatostatin from porcine hypothalami. Biochemistry (1976) 1.46
Solid phase synthesis of growth hormone-release inhibiting factor. Biochem Biophys Res Commun (1973) 1.44
cGMP-mediated Ca2+ release from IP3-insensitive Ca2+ stores in smooth muscle. Am J Physiol (1998) 1.43
Hypothalamic regulatory hormones. Science (1973) 1.41
Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol (1974) 1.40
Hypothalamic neurohormones regulating anterior pituitary function. Recent Prog Horm Res (1968) 1.36
Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies. Fertil Steril (1971) 1.35
Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) (1975) 1.34
Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology (1987) 1.31
Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest (1978) 1.31
Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide. Science (1982) 1.30
Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol (1998) 1.30
The hypothalamus and reproduction. Am J Obstet Gynecol (1972) 1.29
Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med (1975) 1.27
Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol (1998) 1.26
Receptors on smooth muscle cells: characterization by contraction and specific antagonists. Am J Physiol (1982) 1.26
LH-RH agonists and antagonists. Int J Gynaecol Obstet (1980) 1.24
Radioimmunoassay of somatostatin. Metabolism (1978) 1.22
Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest (1977) 1.22
Stoichiometry of neurally induced VIP release, NO formation, and relaxation in rabbit and rat gastric muscle. Am J Physiol (1996) 1.20
Action of the pentapeptide (ICI 50123) on gastric secretion in man. Gastroenterology (1966) 1.19
G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am J Physiol Gastrointest Liver Physiol (2000) 1.18
Stimulation of release and synthesis of luteinizing hormone(LH) and follicle stimulating hormone(FSH) in tissue culture of rat pituitaries in response to natural and synthetic LH and FSH releasing hormone. Endocrinology (1972) 1.17
Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. Am J Physiol (1990) 1.16
Decreased efficacy of polyethylene glycol lavage solution (golytely) in the preparation of diabetic patients for outpatient colonoscopy: a prospective and blinded study. Am J Gastroenterol (2001) 1.15
Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol (1980) 1.15
Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience (1992) 1.14
Vasoactive intestinal peptide as a neural mediator of gastric relaxation. Am J Physiol (1985) 1.14
Nature and kinetics of inhibition of lower esophageal sphincter pressure by glucagon. Gastroenterology (1974) 1.14
Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Mol Pharmacol (1996) 1.14
Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide. Am J Physiol (1977) 1.13
VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells. Am J Physiol (1993) 1.13
Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao. J Biol Chem (1996) 1.12
Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun (1976) 1.12
Letter: Immunohistochemical localization of somatostatin in the rat pancreas. J Histochem Cytochem (1975) 1.12
Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J Med Chem (2000) 1.12
Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am J Physiol (1993) 1.11
Quantitative aspects of synergism and inhibition of gastric acid secretion. Gastroenterology (1968) 1.11
Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-beta1 via Galphaq/11 and to PLC-beta3 via Gbetagammai3. J Biol Chem (1998) 1.11
Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. Endocrinology (1974) 1.10
Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology (1990) 1.07
Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem (1994) 1.05
Effect of intraventricular injection of dopamine, noreprinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology (1979) 1.05
Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation. Am J Physiol (1986) 1.05
Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally. J Med Chem (1971) 1.05
Isolation of the luteinizing hormone and follicle-stimulating hormone-releasing hormone from porcine hypothalami. J Biol Chem (1971) 1.05
Immunohistochemical localization of somatostatin (growth hormone release-inhibiting factor) in the guinea pig brain. Brain Res (1974) 1.05
Heterologous desensitization mediated by G protein-specific binding to caveolin. J Biol Chem (2000) 1.05
Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther (1993) 1.04
Interaction of cA-kinase and cG-kinase in mediating relaxation of dispersed smooth muscle cells. Am J Physiol (1995) 1.04
Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation (1995) 1.03
Evidence for peptide nature of LH and FSH-releasing hormones. Biochem Biophys Res Commun (1971) 1.03
Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut. Gastroenterology (1987) 1.03
Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides (2002) 1.03
Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J Biol Chem (1999) 1.03
Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am J Physiol (1990) 1.02
Comparative effects of gastrin II and histamine on pepsin secretion in man. Gastroenterology (1967) 1.02
Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res (1996) 1.02
Stimulation of gastrin and somatostatin secretion from the isolated rat stomach by bombesin. Am J Physiol (1981) 1.02
Calcium in normal human gastric juice. A four-component model with speculation on the relation of calcium to pepsin secretion. Gastroenterology (1968) 1.02
Inhibition of IP3 and IP3-dependent Ca2+ mobilization by cyclic nucleotides in isolated gastric muscle cells. Am J Physiol (1993) 1.02
Production of antiserum to LH-releasing hormone (LH-RH) associated with gonadal atrophy in rabbits: development of radioimmunoassays for LH-RH. Endocrinology (1973) 1.01
Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke (2000) 1.01
Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity. Gastroenterology (1977) 1.01
Agonist-stimulated cyclic ADP ribose. Endogenous modulator of Ca(2+)-induced Ca2+ release in intestinal longitudinal muscle. J Biol Chem (1995) 1.01
Differential coupling of muscarinic m2 and m3 receptors to adenylyl cyclases V/VI in smooth muscle. Concurrent M2-mediated inhibition via Galphai3 and m3-mediated stimulation via Gbetagammaq. J Biol Chem (1997) 1.01
Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res (1997) 1.00
Release of LH and FSH after administration of synthetic LH-releasing hormone. J Clin Endocrinol Metab (1972) 1.00
Mode of action of cholecystokinin and related peptides on gallbladder muscle. Gastroenterology (1973) 0.99
Postischemic spontaneous hyperthermia and its effects in middle cerebral artery occlusion in the rat. Exp Neurol (2000) 0.99
Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res (1994) 0.98
Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science (1980) 0.98
Blockade of release of growth hormone by brain norepinephrine depletors. Endocrinology (1967) 0.98
Cytosolic calcium during contraction of isolated mammalian gastric muscle cells. Science (1986) 0.98
Bombesin/GRP-stimulated somatostatin secretion is mediated by gastrin in the antrum and intrinsic neurons in the fundus. Am J Physiol (1991) 0.98
Electron microscopic immunohistochemical localization of growth hormone-release inhibiting hormone (somatostatin) in the rat median eminence. Am J Anat (1974) 0.98
Recent approaches to fertility control based on derivative of LH-RH. Vitam Horm (1980) 0.97
Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology (1991) 0.97
Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. Biochem Biophys Res Commun (1977) 0.96
The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. J Clin Invest (1977) 0.95
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide-dependent activation of membrane-bound NO synthase in smooth muscle mediated by pertussis toxin-sensitive Gi1-2. J Biol Chem (1994) 0.95
Anti-NADase values in rheumatic fever and valvular disease. Jpn Circ J (1984) 0.95
Vasoactive intestinal peptide. Relaxant neurotransmitter in tenia coli of the guinea pig. Gastroenterology (1985) 0.95
Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta (1992) 0.95